ClinConnect ClinConnect Logo
Search / Trial NCT06753396

The Effect of Injectable Platelet-Rich Fibrin in Peri-implant Soft Tissue

Launched by KUTAHYA HEALTH SCIENCES UNIVERSITY · Dec 20, 2024

Trial Information

Current as of May 08, 2025

Recruiting

Keywords

Peri Implant Soft Tissue Injectable Platelet Rich Fibrin Platelet Rich Fibrin Phenotype

ClinConnect Summary

This clinical trial is studying how an injection of a substance called platelet-rich fibrin can help improve the health of soft tissues around dental implants, especially in patients who have thin or inadequate gum tissue. Healthy gums are important because they help prevent problems like plaque buildup, inflammation, and loss of bone around the implants. The study will include 80 participants who are healthy, non-smokers, and over 18 years old, but who have less than 2 mm of gum tissue around their implants.

Eligible participants will undergo a procedure where this injectable treatment is applied to their gum areas around the implants. The trial aims to see if this treatment can enhance the thickness and quality of the gum tissue, which may lead to better overall oral health. If you or someone you know has thin gum tissue around dental implants and meets the age and health criteria, this trial may be a good opportunity to explore.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. be over 18 years old
  • 2. The patient does not have any systemic disease
  • 3. Patients who do not smoke or who smoke less than 10 cigarettes
  • 4. Peri-implant keratinized mucosa width less than 2 mm
  • 5. Peri-implant mucosal thickness less than 2 mm
  • Exclusion Criteria:
  • 1. Being out of the defined age group
  • 2. Any systematic contraindication for periodontal surgery
  • 3. Patients who smoke more than 10 cigarettes per day
  • 4. Patients with adequate peri-implant keratinized mucosa width and mucosal thickness
  • 5. Pregnancy
  • 6. Patients taking medication that suppresses the immune system or impairs healing
  • 7. Patients taking medication that impairs the bleeding condition

About Kutahya Health Sciences University

Kutahya Health Sciences University is a premier academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering excellence in medical education and patient care, the university collaborates with leading researchers and healthcare professionals to conduct cutting-edge studies aimed at improving health outcomes. With a focus on translating scientific discoveries into practical applications, Kutahya Health Sciences University plays a vital role in shaping the future of healthcare through rigorous clinical research and interdisciplinary collaboration.

Locations

Kutahya, , Turkey

Patients applied

0 patients applied

Trial Officials

Berceste Güler Ayyıldız, Assoc. Prof. Dr

Study Director

Kütahya Health Sciences University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported